Testicular cancer is one of the most treatable cancers, even when it has spread. The first step in nearly every case is surgically removing the affected testicle, followed by additional treatment if needed based on the stage and type of cancer. The overall cure rate exceeds 95% for early-stage disease, and even advanced cases respond well to chemotherapy.
Surgery Comes First
The standard starting treatment is called a radical inguinal orchiectomy. A surgeon makes an incision in the groin area (not the scrotum) and removes the testicle along with the spermatic cord, which contains blood vessels and nerves that could otherwise allow cancer cells to travel to other parts of the body. This approach is used regardless of stage because it both removes the primary tumor and provides tissue for pathology, which determines exactly what type of cancer you’re dealing with and how aggressive it is.
Recovery from the surgery typically takes several weeks. Most people are advised to avoid sports, running, heavy lifting, and sex for three to four weeks while the incision heals. Losing one testicle does not typically affect your ability to have erections or produce testosterone long-term, since the remaining testicle compensates. If both testicles are affected, which is rare, testosterone replacement becomes necessary.
What Happens After Surgery Depends on the Stage
After the testicle is removed, blood tests and imaging determine how far, if at all, the cancer has spread. There are three broad categories that shape what comes next.
Stage I means the cancer is confined to the testicle. In many cases, no further treatment is needed beyond close monitoring (called active surveillance). Some patients receive a short course of chemotherapy or radiation to reduce the small chance of recurrence, but the cure rate at this stage is extremely high with surgery alone.
Stage II means cancer has reached nearby lymph nodes in the abdomen. Treatment usually involves either radiation therapy (especially for a type called seminoma, which is highly sensitive to radiation) or chemotherapy. For smaller lymph node involvement, radiation is often sufficient. For larger or more numerous affected nodes, chemotherapy is preferred.
Stage III means the cancer has spread to distant lymph nodes or organs like the lungs. Chemotherapy is the primary treatment at this stage, and it remains highly effective.
Chemotherapy for Testicular Cancer
The standard chemotherapy combination uses three drugs: bleomycin, etoposide, and cisplatin, commonly called BEP. For patients with a good prognosis, three cycles of BEP is the typical recommendation. Each cycle lasts about three weeks. In one study, patients treated with BEP had a disease-free rate of 96 to 100%, with only 3% dying of the disease compared to 11% on alternative regimens that dropped one of the three drugs.
Chemotherapy is demanding. Side effects include fatigue, nausea, hair loss, and increased infection risk. But testicular cancer is unusually responsive to these drugs, which is why cure rates remain high even for cancer that has spread to distant sites.
Radiation Therapy
Radiation is primarily used for seminomas, a type of testicular cancer that is exceptionally sensitive to radiation. For Stage I seminoma, radiation targets the abdominal lymph nodes as a preventive measure, using relatively low doses. For Stage II seminoma with limited lymph node involvement (nodes smaller than 3 cm), radiation remains an effective option.
For larger or more advanced disease, chemotherapy generally replaces radiation because it can reach cancer cells throughout the body while avoiding the long-term side effects that come with radiating a wider area.
Lymph Node Surgery
Some patients need a second surgery called retroperitoneal lymph node dissection (RPLND), which removes lymph nodes from the back of the abdomen. This is done in two situations: for early-stage patients where it serves as both a diagnostic and preventive measure, or after chemotherapy when residual masses remain that need to be evaluated or removed.
The complication rate is about 5% for a primary RPLND and around 15% when performed after chemotherapy. The most notable risk is a condition called anejaculation, where the nerves controlling ejaculation are affected. With modern nerve-sparing techniques, this happens in 5 to 10% of primary cases, though the risk is higher after chemotherapy when nerves may be harder to preserve. Serious bleeding from major blood vessels occurs in less than 2% of cases.
Active Surveillance as an Alternative
For Stage I testicular cancer, many patients opt for active surveillance instead of immediate additional treatment after the testicle is removed. This means no chemotherapy or radiation upfront, but a rigorous monitoring schedule to catch any recurrence early. The protocol involves physical exams and blood tests every three to six months during the first year, then less frequently. Imaging scans start as often as every three months for the first six months, then shift to once or twice a year. Surveillance typically continues for up to 10 years.
This approach works because even if the cancer does come back, it’s almost always caught early enough to be cured with treatment at that point. It spares patients the side effects of chemotherapy or radiation unless those treatments actually become necessary.
How Doctors Track Your Response
Three blood markers play a central role in monitoring testicular cancer before, during, and after treatment. These proteins are released by tumor cells, and their levels in the blood reveal whether treatment is working.
After surgery, the markers should drop at predictable rates. One key marker has a half-life of 5 to 7 days, meaning levels should return to normal within about 20 to 28 days if the cancer has been fully removed. Another should normalize within 4 to 6 days after orchiectomy. If levels stay elevated after surgery, it strongly suggests cancer remains elsewhere in the body and chemotherapy is needed.
During chemotherapy, these markers are checked before each cycle. A steady decline at the expected rate signals the treatment is working. Slow decline or failure to normalize raises concern about persistent disease. After treatment is complete, these same markers are checked at every follow-up visit for years, because rising levels are one of the earliest and most accurate indicators of recurrence.
Fertility and Sperm Banking
If you’re of reproductive age and want the option of having biological children, banking sperm before any treatment beyond the initial surgery is critical. Chemotherapy and radiation can both impair sperm production, and predicting the exact impact on any individual is essentially impossible beforehand.
After chemotherapy, some men recover sperm production. Estimates vary widely: some studies report only 20 to 50% of men who become temporarily infertile after treatment will regain sperm production, while others report recovery rates as high as 80%, depending on the specific drugs and doses used. Because of this uncertainty, freezing sperm before treatment starts remains the most reliable safeguard. If sperm aren’t banked before treatment, surgical sperm extraction combined with in-vitro fertilization may still be possible, but it’s more invasive and less predictable.
Long-Term Health After Treatment
Most testicular cancer survivors live full, healthy lives, but treatment does carry some long-term risks worth knowing about. Chemotherapy with cisplatin-based regimens is associated with a 2.7-fold increased risk of leukemia, driven primarily by a 7-fold increase in acute myeloid leukemia during the first 1 to 10 years after diagnosis. This is a real but still uncommon outcome.
Radiation therapy carries a modest increase in cardiovascular risk over time. One study found that patients who received radiation had a cardiac mortality rate about 1.8 times higher than the general population when followed for more than 15 years. This doesn’t appear within the first decade but becomes relevant over a lifetime, which is why doctors factor it into treatment decisions for young men who may live 50 or more years after treatment.
Testosterone levels can drop after losing a testicle, though the remaining one usually compensates. Men who’ve had both testicles removed or who received extensive treatment should have their testosterone monitored and may need replacement therapy. Regular follow-up care after testicular cancer isn’t just about watching for recurrence; it’s also about managing these longer-term health considerations.